GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

被引:0
|
作者
Cryer, Byron [1 ]
Li, Chunming [2 ]
Simon, Lee S. [3 ]
Singh, Gurkirpal [4 ]
Stillman, Martin J. [5 ]
Berger, Manuela [2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Pfizer Inc, New York, NY USA
[3] SDG LLC, Cambridge, MA USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
[5] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P63
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Duloxetine for patients with diabetic peripheral neuropathic pain: A 6-month open-label safety study
    Raskin, Joel
    Wang, Fujun
    Pritchett, Yili Lu
    Goldstein, David J.
    PAIN MEDICINE, 2006, 7 (05) : 373 - 385
  • [42] Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: A prospective, randomized, open-label, blinded end-point trial
    Hermida, Ramon C.
    Ayala, Diana E.
    Khder, Yasser
    Calvo, Carlos
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 108 - 120
  • [43] A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease
    Patterson, CE
    Passmore, AP
    Crawford, VLS
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 144 - 148
  • [44] SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION
    Rovin, Brad
    Furie, Richard
    Houssiau, Frederic A.
    Contreras, Gabriel
    Teng, Y. K. O.
    Curtis, Paula
    Madan, Anuradha
    Jones-Leone, Angela
    Gonzalez-Rivera, Tania
    Okily, Mohamed
    Roth, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [45] The effect of pneumatic trabeculoplasty on intraocular pressure: The results of a 6-month, open-label, multicenter study
    Fogagnolo, P.
    Rossetti, L.
    Marchini, G.
    Marraffa, M.
    Rolando, M.
    Ciancaglini, M.
    Calabria, G.
    Mastropasqua, L.
    Orzalesi, N.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (06) : 922 - 928
  • [46] Effect of recombinant human growth hormone on rotator cuff healing after arthroscopic repair: preliminary result of a multicenter, prospective, randomized, open-label blinded end point clinical exploratory trial
    Oh, Joo Han
    Chung, Seok Won
    Oh, Kyung-Soo
    Yoo, Jae Chul
    Jee, Wonhee
    Choi, Jung-Ah
    Kim, Yang-Soo
    Park, Jin-Young
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2018, 27 (05) : 777 - 785
  • [47] A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-α and diclofenac in rheumatoid arthritis
    Dugina, JL
    Petrov, VI
    Babayeva, AR
    Martyushev-Poklad, AV
    Tcherevkova, EV
    Epstein, OI
    Sergeeva, SA
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 2005, 27 (01): : 15 - 21
  • [48] The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial
    Koshikawa, Yosuke
    Takekita, Yoshiteru
    Kato, Masaki
    Sakai, Shiho
    Onohara, Ai
    Sunada, Naotaka
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Fabbri, Chiara
    Serretti, Alessandro
    Kinoshita, Toshihiko
    NEUROPSYCHOBIOLOGY, 2016, 73 (01) : 35 - 42
  • [49] Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial
    Kratochvil, CJ
    Heiligenstein, JH
    Dittmann, R
    Spencer, TJ
    Biederman, J
    Wernicke, J
    Newcorn, JH
    Casat, C
    Milton, D
    Michelson, D
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (07): : 776 - 784
  • [50] Cilostazol Prevents Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Multicenter Prospective, Randomized, Open-Label Blinded Endpoint Trial
    Senbokuya, Nobuo
    Kinouchi, Hiroyuki
    Kanemaru, Kazuya
    Nishiyama, Yoshihisa
    Yoshioka, Hideyuki
    Horikoshi, Toru
    CEREBROVASCULAR DISEASES, 2012, 34 : 37 - 38